Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
ATTO
Attovia Therapeutics, Inc.
CAPPED RATING
Attovia Therapeutics, Inc. (ATTO) is rated D (1.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Revisions (C+); its weakest is Value (D-).
Quantitative Factor Evaluation • Updated
Overall Rating
1.5
/ 5.0
D
Value
D-
Factor Score
0.8
/ 5.0
Growth
D
Factor Score
1.5
/ 5.0
Profitability
D-
Factor Score
0.8
/ 5.0
Momentum
D+
Factor Score
1.5
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-6.2
EV / EBITDA
-11.6
Rev Growth YoY
N/A
Gross Margin
0.0%
Price Return 3M
-36.6%
Price Return 12M
-32.7%
Catalyst Signal
0.00
Market Cap
$673.1M
TTM Revenue
$1.8M
Price / Sales
374.0
ROE
N/A
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | D- (0.8) | D (1.5) | D- (0.8) | D+ (1.5) | C+ (2.6) | D (1.5) |
| 2026-11-10 | F (0.6) | D+ (1.6) | D- (0.8) | C (2.2) | C+ (2.6) | D+ (1.6) |
| 2026-11-03 | D- (0.8) | D+ (1.6) | D- (0.8) | C- (1.9) | C+ (2.7) | D+ (1.5) |
| 2026-10-27 | D- (1.0) | D+ (1.5) | D- (0.8) | D+ (1.7) | C+ (2.6) | D+ (1.5) |
| 2026-10-20 | D- (1.1) | D+ (1.5) | D- (0.8) | C- (2.1) | C+ (2.6) | D+ (1.6) |
Page
1
of
3